| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| CheckMate 744 | 17-07 | Children, adolescents, and young adults with Classic Hodgkin Lymphoma whose disease has come back or did not respond to initial treatment. |
The purpose of this study is to determine whether certain drug combinations are safe and effective. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| CHRONOS-4 | 17-06 | Indolent (grow slowly) Non-Hodgkin’s Lymphoma that have returned after previous treatment. |
The purpose of this study is to evaluate the efficacy and safety of copanlisib in combination with standard immunochemotherapy. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| CHRONOS-3 | 15-38 | Indolent B-cell non-Hodgkin’s lymphoma that has returned. |
The purpose of this trial is to find out if the drug copanlisib in combination with rituximab is superior to placebo in combination with rituximab. |
| Name | No. | Patient Profile | Purpose |
|---|---|---|---|
| Protocol 04-30 | 15-36 | Myelodysplastic Syndrome after failure of drugs called Hypomethylating Agents |
The purpose of this trial is to evaluate whether adding the drug rigosertib to the patient’s doctor’s choice (standard of care treatment) works better and is as safe as the doctor’s choice. |
Freephone 
Search for a Trial